home / stock / kaly / kaly news


KALY News and Press, Kali Inc

Stock Information

Company Name: Kali Inc
Stock Symbol: KALY
Market: OTC

Menu

KALY KALY Quote KALY Short KALY News KALY Articles KALY Message Board
Get KALY Alerts

News, Short Squeeze, Breakout and More Instantly...

KALY - PAOG 2021 CBD Nutraceuticals Sales Plan Preview This Friday To Include ALKM and USMJ Partnership Highlights

PAOG 2021 CBD Nutraceuticals Sales Plan Preview This Friday To Include ALKM and USMJ Partnership Highlights PR Newswire SANDUSKY, Ohio , May 6, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today highlighted that the upcoming CBD Nutraceutical Sales Rollout ...

KALY - PAOG 2021 CBD Nutraceuticals Rollout Preview This Friday

Sandusky, Ohio--(Newsfile Corp. - May 5, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed a CBD Nutraceutical Sales Rollout Presentation scheduled this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under devel...

KALY - PAOG CBD Nutraceuticals to Hit Market This Year

Sandusky, Ohio--(Newsfile Corp. - May 4, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to present the Company's CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment ...

KALY - PAOG 2021 CBD Nutraceutical Sales Rollout Plan Presentation Scheduled This Friday

Sandusky, Ohio--(Newsfile Corp. - May 3, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced plans to present the company's CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment ...

KALY - PAOG Anticipates Boost to CBD Pharmaceutical Research Initiative from Improving Cannabis Legalization Outlook

Sandusky, Ohio--(Newsfile Corp. - April 28, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today highlighted recent cannabis legalization progress anticipated to enhance PAOG's ongoing CBD Pharmaceutical Development Program. PAOG has partnered with Puration, Inc. (OTC Pink: PURA) to build a pharmac...

KALY - PAOG Announces Opportunity To Expand CBD Pharmaceutical Research

Sandusky, Ohio--(Newsfile Corp. - April 13, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today released a management update on the company's ongoing CBD Pharmaceutical Development Program. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under ...

KALY - PAOG To Publish Latest CBD Pharmaceutical Developments Tomorrow, Tuesday April 13, 2021

PAOG To Publish Latest CBD Pharmaceutical Developments Tomorrow, Tuesday April 13, 2021 PR Newswire SANDUSKY, Ohio , April 12, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today confirmed a management update on the company's ongoing CBD Pharmaceutical Devel...

KALY - PAOG CBD Pharmaceutical Development Update Coming Tomorrow, Tuesday April 13, 2021

Sandusky, Ohio--(Newsfile Corp. - April 12, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed a management update on the Company's ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021. Last year, PAOG acquired RespRx from...

KALY - PAOG Advances CBD Pharmaceutical Developments Backed By US Patent

Sandusky, Ohio--(Newsfile Corp. - April 8, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced a management update on the company's ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021. Last year, PAOG acquired RespRx from ...

KALY - PAOG Targets September 2021 to Introduce CBD Nutraceuticals to Market Co-Packed by ALKM and Marketed Through USMJ

Sandusky, Ohio--(Newsfile Corp. - March 16, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today released details on the Company's nutraceutical developments initiative following last week's introduction of adding CBD RELAX-RX to existing CBD RespRx developments. The details today are highlighted by...

Next 10